SEC Filing Summary: Chromadex Corp. (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Chromadex Corp. (not Niagen Bioscience, Inc.) on December 17, 2013, reporting events occurring on December 11, 2013. The filing addresses a change in the registrant's certifying accountant.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and audit matters.
Material Changes
- Dismissal of Auditor: On December 11, 2013, the Audit Committee approved the dismissal of McGladrey LLP as the Company's independent registered public accounting firm.
- Audit History: McGladrey's reports for fiscal years ended December 29, 2012, and December 31, 2011, did not contain adverse opinions or disclaimers, except for disclosures made in a prior 8-K filed on November 21, 2013.
- Disagreements: The Company reported no disagreements with McGladrey regarding accounting principles, practices, or audit scope during the relevant periods.
Outlook, Risks, and Contingencies
- Internal Control Weaknesses: The filing references a material weakness in internal control over financial reporting identified by McGladrey in a letter dated November 21, 2013.
- Prior Audit Opinion: McGladrey's audit report for the year ended December 31, 2011, stated that the Company had not maintained effective internal control over financial reporting as of that date.
- Exhibits: A letter from McGladrey LLP dated December 17, 2013, confirming their agreement with the Company's disclosures, is filed as Exhibit 16.1.
Investor Verification Checklist
- Verify the identity of the new independent registered public accounting firm appointed to replace McGladrey LLP.
- Review the November 21, 2013, Form 8-K to understand the specific details of the material weakness in internal controls.
- Confirm the status of the Company's remediation efforts regarding the ineffective internal controls over financial reporting.
- Check for any subsequent filings regarding the transition of audit responsibilities.